0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Report & Forecast 2023-2029
Published Date: November 2023
|
Report Code: QYRE-Auto-31H15768
Home | Market Reports | Health| Health Conditions| Cancer
Global and India Chemotherapy Induced Nausea and Vomiting CINV Drugs Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Report & Forecast 2023-2029

Code: QYRE-Auto-31H15768
Report
November 2023
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size

The global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs revenue was US$ 2066 million in 2022 and is forecast to a readjusted size of US$ 2783.8 million by 2029 with a CAGR of 4.3% during the forecast period (2023-2029).

and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market

and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market

Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. In 1983, Coates et al. found that patients receiving chemotherapy ranked nausea and vomiting as the first and second most severe side effects, respectively. Up to 20% of patients receiving highly emetogenic agents in this era postponed, or even refused, potentially curative treatments. Since the 1990s, several novel classes of antiemetics have been developed and commercialized, becoming a nearly universal standard in chemotherapy regimens, and helping to better manage these symptoms in a large portion of patients. Efficient mediation of these unpleasant and sometimes crippling symptoms results in increased quality of life for the patient, and better overall health of the patient, and, due to better patient tolerance, more effective treatment cycles.
In India, the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs key players include Merck, Eisai, Mundipharma, etc. Global top three manufacturers hold a share over 50%.
North America is the largest market, with a share about 50%, followed by China, and Europe both have a share about 35 percent.
In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 60%. And in terms of application, the largest application is Moderately Emetogenic Chemotherapy, followed by Highly Emetogenic Chemotherapy, Low Emetogenic Chemotherapy, etc.
This report focuses on global and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Chemotherapy Induced Nausea and Vomiting (CINV) Drugs will continue to grow rapidly in the future.
Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Scope and Market Size
Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.
For India market, this report focuses on the Chemotherapy Induced Nausea and Vomiting (CINV) Drugs market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Report

Report Metric Details
Report Name and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market
Forecasted market size in 2029 US$ 2783.8 million
CAGR 4.3%
Forecasted years 2023 - 2029
Segment by Type
  • 5-HT3 Inhibitors
  • NK1 Inhibitors
  • Other
Segment by Application
  • Highly Emetogenic Chemotherapy
  • Moderately Emetogenic Chemotherapy
  • Low Emetogenic Chemotherapy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Heron Therapeutics, Roche, Mylan, Tesaro
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market size in 2029?

Ans: The and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market size in 2029 will be US$ 2783.8 million.

What is the market share of major companies in and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market?

Ans: Global top three manufacturers hold a share over 50%.

What is the and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market share by type?

Ans: In terms of product, 5-HT3 Inhibitors is the largest segment, with a share over 60%.

What is the and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market report?

Ans: The main players in the and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market are Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis, Heron Therapeutics, Roche, Mylan, Tesaro

What are the Application segmentation covered in the and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market report?

Ans: The Applications covered in the and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market report are Highly Emetogenic Chemotherapy, Moderately Emetogenic Chemotherapy, Low Emetogenic Chemotherapy, Other

What are the Type segmentation covered in the and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market report?

Ans: The Types covered in the and India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market report are 5-HT3 Inhibitors, NK1 Inhibitors, Other

1 Study Coverage
1.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Introduction
1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Outlook 2018 VS 2022 VS 2029
1.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in US$ Million for the Year 2018-2029
1.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume for the Year 2018-2029
1.3 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Outlook 2018 VS 2022 VS 2029
1.3.1 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in US$ Million for the Year 2018-2029
1.3.2 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume for the Year 2018-2029
1.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4.1 The Market Share of India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in Global, 2018 VS 2022 VS 2029
1.4.2 The Growth Rate of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size, India VS Global, 2018 VS 2022 VS 2029
1.5 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Dynamics
1.5.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Trends
1.5.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Drivers
1.5.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Challenges
1.5.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Type
2.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Segment by Type
2.1.1 5-HT3 Inhibitors
2.1.2 NK1 Inhibitors
2.1.3 Other
2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Type
2.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value, by Type (2018, 2022 & 2029)
2.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Type (2018, 2022 & 2029)
2.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) by Type (2018, 2022 & 2029)
2.3 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Type
2.3.1 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value, by Type (2018, 2022 & 2029)
2.3.2 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Type (2018, 2022 & 2029)
2.3.3 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) by Type (2018, 2022 & 2029)
3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Application
3.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Segment by Application
3.1.1 Highly Emetogenic Chemotherapy
3.1.2 Moderately Emetogenic Chemotherapy
3.1.3 Low Emetogenic Chemotherapy
3.1.4 Other
3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Application
3.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value, by Application (2018, 2022 & 2029)
3.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) by Application (2018, 2022 & 2029)
3.3 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Application
3.3.1 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value, by Application (2018, 2022 & 2029)
3.3.2 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Application (2018, 2022 & 2029)
3.3.3 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Average Selling Price (ASP) by Application (2018, 2022 & 2029)
4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Competitor Landscape by Company
4.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Company
4.1.1 Global Key Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Ranked by Revenue (2022)
4.1.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturer (2018-2023)
4.1.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturer (2018-2023)
4.1.4 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Manufacturer (2018-2023)
4.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Concentration Ratio (CR)
4.2.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in 2022
4.2.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Product Offered and Application
4.5 Global Key Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Company
4.7.1 Key Players of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in India, Ranked by Revenue (2022)
4.7.2 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Players (2018-2023)
4.7.3 India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Players (2018-2023)
5 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region
5.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size in Volume by Region (2018-2029)
5.2.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume by Region: 2018-2023
5.2.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume Forecast by Region (2024-2029)
5.3 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size in Value by Region (2018-2029)
5.3.1 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Region: 2018-2023
5.3.2 Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Region: 2024-2029
6 Americas
6.1 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2018-2029
6.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Type (2018, 2022 & 2029)
6.3 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Application (2018, 2022 & 2029)
6.4 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Country (2018, 2022 & 2029)
6.4.2 Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume by Country (2018, 2022 & 2029)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2018-2029
7.2 EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Type (2018, 2022 & 2029)
7.3 EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Application (2018, 2022 & 2029)
7.4 EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Country (2018, 2022 & 2029)
7.4.2 EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume by Country (2018, 2022 & 2029)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2018-2029
8.2 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Type (2018, 2022 & 2029)
8.3 China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Application (2018, 2022 & 2029)
9 APAC
9.1 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size YoY Growth 2018-2029
9.2 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Type (2018, 2022 & 2029)
9.3 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume, by Application (2018, 2022 & 2029)
9.4 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Facts & Figures by Region (2018, 2022 & 2029)
9.4.1 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Region (2018, 2022 & 2029)
9.4.2 APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume by Region (2018, 2022 & 2029)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Description and Business Overview
10.1.3 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
10.1.5 Merck Recent Development
10.2 Eisai
10.2.1 Eisai Company Information
10.2.2 Eisai Description and Business Overview
10.2.3 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
10.2.5 Eisai Recent Development
10.3 Mundipharma
10.3.1 Mundipharma Company Information
10.3.2 Mundipharma Description and Business Overview
10.3.3 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
10.3.5 Mundipharma Recent Development
10.4 Qilu Pharma
10.4.1 Qilu Pharma Company Information
10.4.2 Qilu Pharma Description and Business Overview
10.4.3 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
10.4.5 Qilu Pharma Recent Development
10.5 Teva
10.5.1 Teva Company Information
10.5.2 Teva Description and Business Overview
10.5.3 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
10.5.5 Teva Recent Development
10.6 Novartis
10.6.1 Novartis Company Information
10.6.2 Novartis Description and Business Overview
10.6.3 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
10.6.5 Novartis Recent Development
10.7 Heron Therapeutics
10.7.1 Heron Therapeutics Company Information
10.7.2 Heron Therapeutics Description and Business Overview
10.7.3 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
10.7.5 Heron Therapeutics Recent Development
10.8 Roche
10.8.1 Roche Company Information
10.8.2 Roche Description and Business Overview
10.8.3 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
10.8.5 Roche Recent Development
10.9 Mylan
10.9.1 Mylan Company Information
10.9.2 Mylan Description and Business Overview
10.9.3 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
10.9.5 Mylan Recent Development
10.10 Tesaro
10.10.1 Tesaro Company Information
10.10.2 Tesaro Description and Business Overview
10.10.3 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Products Offered
10.10.5 Tesaro Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Industry Chain Analysis
11.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Mode & Process
11.4 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales and Marketing
11.4.1 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Channels
11.4.2 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors
11.5 Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs CAGR in Value, India VS Global, 2018 VS 2022 VS 2029
    Table 2. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Trends
    Table 3. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Drivers
    Table 4. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Challenges
    Table 5. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Restraints
    Table 6. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturer, (US$ Million), 2018-2023
    Table 12. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturer, 2018-2023
    Table 13. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturer, (K Units), 2018-2023
    Table 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Manufacturer, 2018-2023
    Table 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Manufacturer (2018-2023) & (USD/Unit)
    Table 16. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 17. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chemotherapy Induced Nausea and Vomiting (CINV) Drugs as of 2022)
    Table 18. Global Key Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Manufacturing Base Distribution and Headquarters
    Table 19. Global Key Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Product Offered and Application
    Table 20. Global Key Manufacturers of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs, Date of Enter into This Industry
    Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 22. Key Players of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs in India, Ranked by Revenue (2022) & (US$ million)
    Table 23. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue by Players, (US$ Million), (2018-2023)
    Table 24. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Players, (2018-2023)
    Table 25. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Players, (K Units), (2018-2023)
    Table 26. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Share by Players, (2018-2023)
    Table 27. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 28. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume by Region (2018-2023) & (K Units)
    Table 29. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume Forecast by Region (2024-2029) & (K Units)
    Table 30. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Region (2018-2023) & (US$ Million)
    Table 31. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Forecast by Region (2024-2029) & (US$ Million)
    Table 32. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Country (2018-2023) & (US$ Million)
    Table 34. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Country (2024-2029) & (US$ Million)
    Table 35. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume by Country (2018-2023) & (K Units)
    Table 36. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume by Country (2024-2029) & (K Units)
    Table 37. EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Country (2018-2023) & (US$ Million)
    Table 39. EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Country (2024-2029) & (US$ Million)
    Table 40. EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume by Country (2018-2023) & (K Units)
    Table 41. EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume by Country (2024-2029) & (K Units)
    Table 42. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 43. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Country (2018-2023) & (US$ Million)
    Table 44. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Country (2024-2029) & (US$ Million)
    Table 45. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume by Country (2018-2023) & (K Units)
    Table 46. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume by Country (2024-2029) & (K Units)
    Table 47. Merck Company Information
    Table 48. Merck Description and Business Overview
    Table 49. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 50. Merck Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
    Table 51. Merck Recent Development
    Table 52. Eisai Company Information
    Table 53. Eisai Description and Business Overview
    Table 54. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 55. Eisai Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
    Table 56. Eisai Recent Development
    Table 57. Mundipharma Company Information
    Table 58. Mundipharma Description and Business Overview
    Table 59. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 60. Mundipharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
    Table 61. Mundipharma Recent Development
    Table 62. Qilu Pharma Company Information
    Table 63. Qilu Pharma Description and Business Overview
    Table 64. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 65. Qilu Pharma Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
    Table 66. Qilu Pharma Recent Development
    Table 67. Teva Company Information
    Table 68. Teva Description and Business Overview
    Table 69. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 70. Teva Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
    Table 71. Teva Recent Development
    Table 72. Novartis Company Information
    Table 73. Novartis Description and Business Overview
    Table 74. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 75. Novartis Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
    Table 76. Novartis Recent Development
    Table 77. Heron Therapeutics Company Information
    Table 78. Heron Therapeutics Description and Business Overview
    Table 79. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 80. Heron Therapeutics Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
    Table 81. Heron Therapeutics Recent Development
    Table 82. Roche Company Information
    Table 83. Roche Description and Business Overview
    Table 84. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 85. Roche Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
    Table 86. Roche Recent Development
    Table 87. Mylan Company Information
    Table 88. Mylan Description and Business Overview
    Table 89. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 90. Mylan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
    Table 91. Mylan Recent Development
    Table 92. Tesaro Company Information
    Table 93. Tesaro Description and Business Overview
    Table 94. Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 95. Tesaro Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product
    Table 96. Tesaro Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Customers List
    Table 100. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Product Picture
    Figure 2. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size 2018-2029 (US$ Million)
    Figure 4. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2018-2029 (K Units)
    Figure 5. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
    Figure 6. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Size 2018-2029 (US$ Million)
    Figure 7. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales 2018-2029 (K Units)
    Figure 8. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share in Global, in Value (US$ Million) 2018-2029
    Figure 9. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share in Global, in Volume (K Units) 2018-2029
    Figure 10. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Report Years Considered
    Figure 11. Product Picture of 5-HT3 Inhibitors
    Figure 12. Product Picture of NK1 Inhibitors
    Figure 13. Product Picture of Other
    Figure 14. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Type in 2022 & 2029
    Figure 15. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 16. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Value by Type (2018-2029)
    Figure 17. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2018-2029) & (K Units)
    Figure 18. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 19. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2018-2029) & (USD/Unit)
    Figure 20. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Type in 2022 & 2029
    Figure 21. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Type (2018-2029) & (US$ Million)
    Figure 22. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Value by Type (2018-2029)
    Figure 23. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2018-2029) & (K Units)
    Figure 24. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 25. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Type (2018-2029) & (USD/Unit)
    Figure 26. Product Picture of Highly Emetogenic Chemotherapy
    Figure 27. Product Picture of Moderately Emetogenic Chemotherapy
    Figure 28. Product Picture of Low Emetogenic Chemotherapy
    Figure 29. Product Picture of Other
    Figure 30. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Application in 2022 & 2029
    Figure 31. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 32. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Value by Application (2018-2029)
    Figure 33. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2018-2029) & (K Units)
    Figure 34. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 35. Global Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2018-2029) & (USD/Unit)
    Figure 36. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Market Share by Application in 2022 & 2029
    Figure 37. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value by Application (2018-2029) & (US$ Million)
    Figure 38. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Value by Application (2018-2029)
    Figure 39. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2018-2029) & (K Units)
    Figure 40. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 41. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Price by Application (2018-2029) & (USD/Unit)
    Figure 42. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 43. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 44. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2018-2029) & (K Units)
    Figure 45. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 46. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2018-2029) & (K Units)
    Figure 47. Americas Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 48. United States Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 49. Canada Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Mexico Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 51. Brazil Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 52. EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 53. EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 54. EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2018-2029) & (K Units)
    Figure 55. EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 56. EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2018-2029) & (K Units)
    Figure 57. EMEA Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 58. Europe Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 59. Middle East Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 60. Africa Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 61. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 62. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 63. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2018-2029) & (K Units)
    Figure 64. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 65. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2018-2029) & (K Units)
    Figure 66. China Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 67. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Volume Growth Rate 2018-2029 (K Units)
    Figure 68. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate 2018-2029 (US$ Million)
    Figure 69. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Type (2018-2029) & (K Units)
    Figure 70. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Type (2018-2029)
    Figure 71. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales by Application (2018-2029) & (K Units)
    Figure 72. APAC Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share in Volume by Application (2018-2029)
    Figure 73. Japan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 74. South Korea Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 75. China Taiwan Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 76. Southeast Asia Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 77. India Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Sales in Value Growth Rate (2018-2029) & (US$ Million)
    Figure 78. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Value Chain
    Figure 79. Chemotherapy Induced Nausea and Vomiting (CINV) Drugs Production Process
    Figure 80. Channels of Distribution
    Figure 81. Distributors Profiles
    Figure 82. Bottom-up and Top-down Approaches for This Report
    Figure 83. Data Triangulation
    Figure 84. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Radioactive Iodine Ablation Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9U20281
Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global AI Contouring Software for Radiotherapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-32T20006
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Cell Senescence β-Galactosidase Staining Kit Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-0Q20500
Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Kinase Inhibitors For Cancer Treatment Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages
Type: Report
Code: QYRE-Auto-18V16958
Wed Nov 12 00:00:00 UTC 2025

Add to Cart